ACIP Strengthens Pneumococcal Vaccine Guidance (CME/CE)

(MedPage Today) -- Children and teens ages 6 through 18 who have certain high-risk conditions should receive the 13-valent pneumococcal conjugate vaccine (PCV13, Prevnar 13), according to strengthened recommendations from the CDC's Advisory Committee on Immunization Practices (ACIP).
Source: MedPage Today Infectious Disease - Category: Infectious Diseases Source Type: news